Background: Patients who receive surgery from high-volume surgeons tend to have better outcomes. Black patients, however, are less likely to receive surgery from high-volume surgeons.
R eceiving surgery from a high-volume surgeon has been associated with improved outcomes for a wide variety of procedures including lower rates of 30-day surgical complications, lower rates of mortality, and, for cancer surgery, lower rates of recurrence. 1, 2 However, access to high-volume surgeons remains unequal. Racial disparities in treatment by high-volume surgeons have been described for multiple cancer [3] [4] [5] [6] [7] [8] and noncancer surgeries, 5, 6, 9 and have persisted over time. 8 Although racial disparities in treatment by high-volume surgeons have been widely documented, reasons underlying these disparities remain poorly understood. In general, there are 2 pathways through which a patient may be treated by a high-volume surgeon: (1) the patient may be diagnosed by a high-volume surgeon and remain with that surgeon or change to another high-volume surgeon for treatment; or (2) the patient may be diagnosed by a low-volume surgeon and then change to a high-volume surgeon for treatment. Understanding the relative contribution of each pathway to racial disparities in use of high-volume surgeons is an important step toward addressing these disparities.
We focus on racial disparities in use of high-volume urologists for men with prostate cancer. In 2010, an estimated 217,730 men were diagnosed with prostate cancer in the United States, and radical prostatectomy is one of the primary treatment options. 10 High-volume urologists tend to have lower rates of postoperative and urinary complications, 11 shorter hospital lengths of stay, 12 decreased likelihood of positive surgical margins, 12 and improved recurrence-free survival. 3 However, previous literature suggests that black men with localized prostate cancer are less likely to be operated on by high-volume urologists and at high-volume hospitals than white men. 12 We examined the degree to which differences in treatment by a high-volume urologist between black and white men with localized prostate cancer is attributable to differences in rates of diagnosis by a high-volume urologist versus differences in rates of changing from a low-volume urologist at diagnosis to a high-volume urologist for treatment. We further examined to what extent racial differences in rates of changing from a low-volume to a high-volume urologist are attributable to black and white men being diagnosed by different low-volume urologists or having different rates of changing to high-volume urologists after being diagnosed by the same low-volume urologists.
METHODS

Data Sources
The study was a retrospective, observational cohort study using registry and administrative claims data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. The SEER-Medicare database links patient demographic and tumor-specific data collected by SEER cancer registries to longitudinal healthcare claims for Medicare enrollees. 13 This study was approved by the University of Pennsylvania and Johns Hopkins University School of Medicine Institutional Review Boards.
Study Population
We identified men aged 65 years or above who were diagnosed with prostate cancer from 1995 to 2005 in 1 of the SEER sites. Data on patients with incomplete Medicare records (ie, those enrolled in health maintenance organizations or not enrolled in fee-for-service Medicare program) were excluded. The sample was limited to 29,751 men with localized or regional disease defined as American Joint Committee on Cancer stage 1, 2, or 3 without nodal invasion or metastases who underwent prostatectomy. Prostatectomy was identified from Medicare inpatient, outpatient, and physician/supplier component files as described previously. 14, 15 These men were matched to a diagnosing (29,398; 98 .8%) and treating urologist (27, 274 ; 91.7%), see below. Patients of all race/ethnicity were included when classifying urologists' prostatectomy volume. However, the sample was limited to white and black men for analyses to examine black/white disparities (N = 26,058).
Assignment of Patients to Urologists Diagnosing Urologist
The urologist most likely to have diagnosed the patient's prostate cancer was defined as the urologist who billed for a prostate biopsy in the 3 months before the date of diagnosis. If no claim was identified, then the urologist was chosen based on the following order: (a) the urologist who billed for a claim on the date of diagnosis; (b) the urologist who billed for the greatest number of visits in the 3-month window before diagnosis, and (c) the urologist who billed for the greatest number of claims in the 3 months after diagnosis. Provider specialty was determined using codes from the Medicare Physician Identification and Eligibility Registry data. We focused on diagnosing urologist because of their potential role in treatment selection. Patients were matched to 2538 unique diagnosing urologists.
Treating Urologist
The urologist who billed for the patient's prostatectomy was defined as the treating urologist. Patients were matched to 2000 unique treating urologists.
Urologist Prostatectomy Volume
Yearly volume was identified by summing the number of prostatectomies for which a urologist billed divided by the total number of years in which the urologist performed at least 1 prostatectomy. Urologists were classified into 4 volume categories based on quartiles of the patient cohort. The median patient volume for treating urologists in the lowest volume quartile was 1.8 patients (range, 1.0 to 2.5) to 9.8 patients in the highest quartile (range, 6.8 to 23.5). The same cut-points for patient volume were applied to the diagnosing urologist's surgical volume. Diagnosing urologists who did not bill for any prostatectomies during the study period (N = 695) were given a volume of 0 and placed in the lowest volume quartile. High volume for diagnosing and treating urologists is defined as being in the top quartile of the sample distribution, and low-volume is defined as the bottom 3 quartiles.
Patient and Tumor Characteristics
Age was classified as 65-74 years and 75 years and above. Individuals were considered black if they were classified as black without a codesignation of Hispanic or Asian and white if they were classified as white without a classification of black. Patient comorbidities were identified by classifying all available inpatient and outpatient Medicare claims for the 90-day interval preceding prostate cancer diagnosis into 46 categories. [16] [17] [18] [19] For clarity, comorbidity is reported as the number (0, 1, Z2) of the possible 46 comorbidity groups identified for each patient. Marital status was classified as married, single, or unknown. US census information was used as a proxy for individual measures of socioeconomic status. Men were linked to their census tract and, when not available, zip code to determine median income which was classified into quartiles. Tumor grade corresponds to Gleason status and was categorized as well differentiated, moderately differentiated, poorly differentiated and undifferentiated, and unknown.
Statistical Analyses
After presenting descriptive statistics by patient race, we estimated a multivariable logistic regression model where the dependent variable was the volume status (high/low) of the treating urologist. The model adjusted for sociodemographic factors, comorbidities, tumor grade and stage, SEER site, and year of diagnosis. We performed a similar multivariable logistic regression model with the volume status of the diagnosing urologist as the dependent variable.
In the next series of models, we estimated multinomial logistic regression models for patients diagnosed by low and, separately, high-volume urologists. The dependent variable categorized patients according to whether they: (a) did not change physicians (baseline category); (b) changed to a low-volume treating urologist; and (c) changed to a highvolume treating urologist. We clustered standard errors by patients' diagnosing urologists.
For patients diagnosed by low-volume urologists, we then explored the extent to which overall racial differences in rates of changing may be attributable to systematic differences between urologists who care for patients of different races (between-doctor differences) versus variation in how urologists care for patients of different races (within-doctor differences). That is, black patients diagnosed by lowvolume urologists might be more or less likely to change physicians than white patients also diagnosed by low-volume urologists. This may be because physicians who diagnose predominantly black patients may care for patients differently compared with those who diagnose predominantly white patients, or because physicians may treat their black patients differently than their white patients. The explanations are not mutually exclusive. To assess this empirically, we specified a hybrid-fixed effects model 20,21 by adding to the above multinomial regression model covariates that specify, for each diagnosing urologist, the proportion of his/ her patients belonging to each racial group. The coefficients on these variables captured between-doctor differences whereas the coefficients on the patient-level race/ethnicity variables identify the within-doctor differences. 22 As a robustness check of the within-doctor differences, we estimated a conditional fixed effects logistic regression of the dichotomous outcome of change to a high-volume treating urologist. Analyses were conducted using Stata 11.1. Hypothesis tests were 2-sided and used a type I error rate of 0.05. Table 1 presents the characteristics of the patient population, stratified by patient race. With the exception of year and tumor grade, significant racial differences were noted with each sociodemographic and clinical characteristic. Similar to prior studies, black men were less likely to have had their surgery from a high-volume urologist and this difference persisted after adjustment for sociodemographic and clinical characteristics [odds ratio (OR) 0.76; 95% confidence interval (CI), 0.67-0.87] ( Table 2 ). In addition, men living in the highest income neighborhoods, patients with lower levels of comorbidity, and those with higher Gleason scores were significantly more likely to be treated by high-volume urologists. Figure 1 shows the flow of patients according to the volume of their diagnosing and treating urologist. In total, 14.0% of patients were diagnosed by a high-volume urologist and 86.0% were diagnosed by a low-volume urologist. A lower proportion of black patients were diagnosed by a highvolume urologist compared with white patients (9.2% vs. 14.4%, P < 0.001). However, this difference was no longer statistically significant after adjustment for sociodemographic and clinical characteristics ( Table 2 ). Being 75 years of age or older and residing in neighborhoods with higher incomes (compared with the lowest quartile) were significantly associated with higher likelihood of diagnosis by a high-volume urologist even after adjustment for other patient characteristics.
RESULTS
Among men diagnosed by a low-volume urologist, nearly half (46.0%) changed urologists for treatment: 14.2% to a high-volume urologist and 31.8% to a different lowvolume urologist. Black men were less likely to change urologists (36.4% vs. 46.8%) and less likely to change to a high-volume urologist than white men (9.2% vs. 14.6%, P < 0.001). In contrast, lower rates of changing urologists were observed among patients diagnosed by a high-volume urologist: only 10.7% changed urologists for treatment and approximately half of those patients (48.7%) changed to another high-volume urologist. There were no significant racial differences in changing urologists after being diagnosed by a high-volume urologist. Nearly all (94.5%) of patients diagnosed by a high-volume urologist received their prostatectomy from a high-volume urologist.
Separate multinomial logistic regression models were run among men diagnosed by low and high-volume urologists to examine the effect of multivariate adjustment on racial differences in changing urologists (Table 3 ). In both models, the outcome categories are not changing urologists (baseline), changing to a low-volume urologist, and changing to a high-volume urologist. Among men diagnosed by a lowvolume urologist, black men remained significantly less likely to change to a high-volume urologist [relative risk ratio (RRR) 0.61; 95% CI, 0.47-0.79] compared with white men. Black men were also significantly less likely to change to a different low-volume urologist [(RRR 0.72; 95% CI, 0.59-0.87). Older age and higher number of comorbidities were associated with a lower likelihood of changing to either a high-volume or another low-volume urologist, whereas residing in higher income neighborhoods and a higher Gleason score were associated with an increased likelihood of changing to a high-volume urologist but not to another low-volume urologist. Among men diagnosed by a highvolume urologist, racial differences in changing urologists were not statistically significant. However, men who resided in higher income neighborhoods were more likely to change to a different high-volume treating urologist (RRR 1.75; 95% CI, 1.02-2.98). The last model examined whether rates of changing from a low-volume urologist could be attributed to black and white men being diagnosed by different low-volume urologists (between-doctor differences) versus black and white men having different rates of changing urologists after being diagnosed by the same low-volume urologists (withindoctor effects) (see Appendix Table 1 , Supplemental Digital Content 1, http://links.lww.com/MLR/A249). Among patients diagnosed by the same low-volume urologist, black patients were significantly less likely to change to a high-volume urologist compared with white patients (within-doctor effects, RRR 0.81; 95% CI, 0.67-0.97). Between-doctor effects were also significant with lower rate of changing to a high-volume urologist observed for all patients (regardless of race) who were diagnosed by urologists who had a greater proportion of black patients (RRR 0.36; 95% CI, 0.17-0.78). Using conditional logistic regression analyses led to qualitatively similar results for the within-doctor effects.
DISCUSSION
In this analysis of prostatectomy for localized prostate cancer among elderly black and white men, we found that 40.1% of patients had a different diagnosing and treating urologist. Black men were less likely to undergo prostatectomy by a high-volume urologist than white men, and this disparity was largely attributable to lower rates of changing from a low-volume urologist at diagnosis to a high-volume urologist for treatment. To our knowledge, this is the first study to demonstrate that racial differences in treatment by a high-volume surgeon can be attributed to differences in the probability of changing surgeons. These results have important implications for efforts to address racial disparities in treatment by high-volume surgeons.
Currently very little is known about what drives the selection of a surgeon or movement from a low-volume to a high-volume surgeon for treatment. 18 Prior research has tended to focus on why patients change their primary care providers. [23] [24] [25] [26] [27] [28] [29] [30] Trust and satisfaction have been shown to be important predictors of changing one's usual source of care, [23] [24] [25] [26] [28] [29] [30] although these may have different meanings and be given different importance in the context of surgeon selection. Katz et al 31 found that women with breast cancer who chose their surgeon based on reputation were more likely to be treated by a high-volume surgeon compared with women who were referred or who chose based on proximity. Although surgeon volume may be correlated with reputation, it is uncertain whether patients and their referring doctors are directly aware of surgeon volume and how it factors into their decision-making relative to other attributes of the surgeon and his/her practice. 32, 33 In addition, travel distance and the spatial distribution of high-volume urologists are likely important factors in surgeon selection. 8, 34, 35 Evidence suggests that with the increasing centralization of prostate cancer surgery at high-volume hospitals, travel distances for patients have increased over time. 35 Although we did not directly assess the factors that determine racial differences in changing urologists, our results suggest that these differences arose both because of racial differences in which low-volume urologist black and white patients see at the time of diagnosis (between-doctor effects) and because of racial differences in changing from the same diagnosing urologist (within-doctor effects). The finding that black and white patients tended to be diagnosed by different low-volume urologists is not surprising given the considerable evidence supporting racial differences in providers in many other settings. High levels of segregation have been documented in the healthcare system, 29 including in primary and hospital care. 36, 37 Furthermore, providers who care for greater proportions of minority patients have been found to have different access to institutional resources and different quality and patient outcomes. 30, [38] [39] [40] Here, diagnosing urologists who treated a greater proportion of black patients were less likely to have their patients change to a high-volume urologist than diagnosing urologists who cared for a smaller proportion of black patients. This difference occurred even though these urologists do not differ in surgical volume themselves and the patients all had the same insurance. Although it is interesting to speculate that this pattern may be driven by factors such as practice structure (eg, solo vs. group), strength of hospital affiliation, or spatial distribution of providers with respect to where patients live, further research is needed to understand the factors underlying this variation.
Our results further suggest that black and white patients who were diagnosed by the same urologist had different rates of changing to high-volume surgeons. This pattern may relate to diagnosing urologists making different recommendations about referral for their black and white patients. Using clinical vignettes, Denberg et al 41 found that urologists gave different recommendations regarding prostate cancer treatment for patients of different races and social vulnerability. Differences in recommendations by patient race may stem from a variety of factors including physician-bias, heuristics, or clinical uncertainty. 42, 43 Alternatively, patient decision-making and preferences may also drive the observed patterns of changing urologists. 44 It is possible that differences in doctor-patient communication, 45, 46 trust, 40, 47, 48 access to care, 49 access to new technology (eg, robotic prostatectomy), 50 and ability to travel (eg, financial, time, and psychological costs) 34 may be important determinants of patient decisions to change urologists and may vary by race.
Black men were less likely to be diagnosed by a highvolume urologist; however, this association was largely explained by other factors. In particular, diagnosis by a highvolume urologist was significantly associated with residing in a higher income areas. Higher area income was also strongly associated with changing from a low-volume to a high-volume urologist. Area-level income may correlate with the local availability of high-volume urologists and be a proxy for patient-level factors (eg, economic resources, selfefficacy, and literacy) that may predispose individuals to receive their diagnosis and treatment from high-volume providers. It is possible that academic medical centers, which are frequently located in low-income, inner-city areas, may serve to mitigate these racial and socioeconomic disparities. 51 The results of this study need to be considered in light of its limitations. First, prostatectomy volume was based on SEER-Medicare claims and has the potential for misclassification error. Medicare volume has been shown to accurately reflect total urologist prostatectomy volume, 2 but it is possible that patients traveling outside of a SEER site to receive treatment might lead to that treating urologist being inaccurately classified as low-volume as patients from outside of the SEER site are not captured. Second, our matching of patients to their diagnosing and treating physicians was incomplete. Third, the definition of the diagnosing urologist was based on claims data rather than patient-report and has the potential for misclassification error. Fourth, we were unable to account for practice structure that may affect both the rates of provider changing and decisions about which specific doctor to see. Fifth, although we used average patient volume over the years in practice in defining urologist volume, the number of cases a physician performs may vary year to year. Sensitivity analyses that defined high-volume providers as the top 2 quartiles of the sample distribution revealed qualitatively similar results (see Appendix Tables 2 and 3 Sixth, we excluded men who may have been referred to a high-volume or low-volume treating urologist but did not undergo surgery; this may lead to biased estimates of the association between race and changing urologists. Although we were unable to observe physician recommendations in claims data, we ran additional analyses examining rates of changing doctors among all men diagnosed with localized prostate cancer regardless of treatment (see Appendix 1, Supplemental Digital Content 1, http://links.lww.com/MLR/A249 for a complete description). In adjusted analyses, black patients were significantly less likely to be diagnosed by a highvolume urologist (OR 0.85; 95% CI, 0.78-0.93) and, among those diagnosed by a low-volume urologist, less likely to change to a high-volume urologist for their follow-up care. The results support our main findings. Finally, relying on urologist volume as the sole marker of quality has potential limitations, and disparities in recurrence-free survival and mortality has been shown to persist among black and white men who received their prostatectomy from medium and highvolume urologists and hospitals. 3 The current study demonstrates high rates of changing urologists between diagnosis and surgical treatment. However, black men were significantly less likely to change overall and less likely to change to a high-volume urologist for their surgical treatment. The potential benefits of receiving care from high-volume urologists may be substantial-for example, compared with low-volume urologists, high-volume urologists tend to have fewer in-hospital (12% vs. 22%) 12 and late urinary complications (20% vs. 28%), 11 and longer time to recurrence (73 vs. 60 mo for the 25th percentile). 3 However, to realize these benefits, interventions that attempt to reduce disparities in access to high-volume surgeons will require a deeper understanding of the specific pathways through which patients come to receive surgical care. Particular attention should be paid to disentangling the patient-level, physician-level, and systemlevel factors that may impede black and low-income patients from changing urologists. To the extent that patient choice drives surgeon selection, then patients will need to be educated about the importance of asking about surgical volume. If physician-level factors predominate, then awareness campaigns may need to target referring physicians. Finally, systemicbarriers including differential institutional resources, uneven spatial distribution of providers, barriers to patient-travel may need to be addressed to mitigate disparities in treatment by high-volume urologists.
